Can a longer course of TARPEYO protect kidneys in IgA disease?
Disease control
Recruiting now
This study looks at whether taking TARPEYO (budesonide) for more than 9 months can further help adults with IgA nephropathy, a kidney disease. About 60 people who have already completed 9 months of TARPEYO will take it for another 19 months. Researchers will check urine and blood…
Phase: PHASE4 • Sponsor: Calliditas Therapeutics AB • Aim: Disease control
Last updated May 26, 2026 12:04 UTC